![conference banner](/images/conference-banner.jpeg)
Abstract
From the fresh fruiting bodies of the mushroom Pleurotus eryngii a phytase with a molecular mass of 14 kDa was isolated. The isolation protocol entailed ion exchange chromatography on DEAE-cellulose and CM-cellulose, affinity chromatography on Affi-gel blue gel, and ion exchange chromatography on Q-Sepharose. The phytase was unadsorbed on DEAE-cellulose, CM-cellulose and Affi-gel blue gel, and adsorbed on Q-Sepharose. It appeared as a single band in SDSPAGE. It exhibited maximal activity at around 37°C. Its activity underwent little changes over the range of pH 3.0 to 9.0. The aforementioned characteristics are different from those of animal, plant and bacterial phytases. The low molecular mass and pH stability of P. eryngii phytase also distinguish it from mushroom phytases and other fungal phytases reported earlier. The purified enzyme exhibited a broad substrate specificity on a range of phosphorylated compounds, and the phytase demonstrated the N-terminal sequence ADNVYRHDNN which shows little homology to known phytases. It inhibited proliferation of human nasopharyngeal carcinoma CNE2 cells, hepatoma HepG2 cells and breast cancer MCF7 cells with an IC50 of 1.9 µM, 2.9 µM, and 1.0 µM, respectively.
Keywords: Phytas isolation, Pleurotus eryngii, antiproliferative, fruiting bodies, mushroom, chromatography, fungal phytase, nasopharyngeal carcinoma, hepatoma
Protein & Peptide Letters
Title:Isolation of a Phytase with Distinctive Characteristics from an Edible Mushroom, Pleurotus eryngii
Volume: 20 Issue: 4
Author(s): Miao Li, Hexiang Wang and Tzi Bun Ng
Affiliation:
Keywords: Phytas isolation, Pleurotus eryngii, antiproliferative, fruiting bodies, mushroom, chromatography, fungal phytase, nasopharyngeal carcinoma, hepatoma
Abstract: From the fresh fruiting bodies of the mushroom Pleurotus eryngii a phytase with a molecular mass of 14 kDa was isolated. The isolation protocol entailed ion exchange chromatography on DEAE-cellulose and CM-cellulose, affinity chromatography on Affi-gel blue gel, and ion exchange chromatography on Q-Sepharose. The phytase was unadsorbed on DEAE-cellulose, CM-cellulose and Affi-gel blue gel, and adsorbed on Q-Sepharose. It appeared as a single band in SDSPAGE. It exhibited maximal activity at around 37°C. Its activity underwent little changes over the range of pH 3.0 to 9.0. The aforementioned characteristics are different from those of animal, plant and bacterial phytases. The low molecular mass and pH stability of P. eryngii phytase also distinguish it from mushroom phytases and other fungal phytases reported earlier. The purified enzyme exhibited a broad substrate specificity on a range of phosphorylated compounds, and the phytase demonstrated the N-terminal sequence ADNVYRHDNN which shows little homology to known phytases. It inhibited proliferation of human nasopharyngeal carcinoma CNE2 cells, hepatoma HepG2 cells and breast cancer MCF7 cells with an IC50 of 1.9 µM, 2.9 µM, and 1.0 µM, respectively.
Export Options
About this article
Cite this article as:
Li Miao, Wang Hexiang and Bun Ng Tzi, Isolation of a Phytase with Distinctive Characteristics from an Edible Mushroom, Pleurotus eryngii, Protein & Peptide Letters 2013; 20 (4) . https://dx.doi.org/10.2174/0929866511320040010
DOI https://dx.doi.org/10.2174/0929866511320040010 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells
Current Cancer Drug Targets Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancer
Recent Patents on Anti-Cancer Drug Discovery Investigations on the Biological Activity of <i>Allium sativum</i> Agglutinin (ASA) Isolated from Garlic
Protein & Peptide Letters Current Targets for Anticancer Drug Discovery
Current Drug Targets Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer
Current Drug Targets Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers
Current Drug Targets MiRNAs Overexpression and Their Role in Breast Cancer: Implications for Cancer Therapeutics
Current Drug Targets Hybrid Compounds & Oxidative Stress Induced Apoptosis in Cancer Therapy
Current Medicinal Chemistry Microparticles in Health and Disease: Small Mediators, Large Role?
Current Vascular Pharmacology Homochiral Drugs: A Demanding Tendency of the Pharmaceutical Industry
Current Medicinal Chemistry Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer
Current Cancer Drug Targets Effects of Edible Algae Polysaccharides on Allergic, Inflammatory, and Anti-Tumor Responses Through Toll-Like Receptor 4
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Promoter Structure and Transcriptional Regulation of Human β-Galactoside α2, 3-Sialyltransferase Genes
Current Drug Targets Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets From Nonsteroidal Aromatase Inhibitors to Multifunctional Drug Candidates: Classic and Innovative Strategies for the Treatment of Breast Cancer
Current Topics in Medicinal Chemistry Differentiation of Non-Pharmacological from Pharmacological Dopamine Release in the Living Human Brain
Current Medical Imaging The Current and Evolving Role of Immunotherapy in Metastatic Colorectal Cancer
Current Cancer Drug Targets Synthesis of New Thioureas Derivatives and Evaluation of Their Efficacy as Proliferation Inhibitors in MCF-7 Breast Cancer Cells by Using <sup>99m</sup>Tc-MIBI Radiotracer
Medicinal Chemistry Gene Therapy for Gastric Diseases
Current Gene Therapy Tyrosine Kinases and Inflammatory Signalling
Current Molecular Medicine